Haematologica: Mutations in RAS-BRAF-MAPK-ERK pathway define…

Artículo del grupo de Biología Molecular del Cáncer en Haematologica

 

Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia.
 

Link to Medline